Brian A. Sparling

437 total citations
15 papers, 283 citations indexed

About

Brian A. Sparling is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Brian A. Sparling has authored 15 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Brian A. Sparling's work include Catalytic C–H Functionalization Methods (2 papers), Computational Drug Discovery Methods (2 papers) and Natural Compound Pharmacology Studies (2 papers). Brian A. Sparling is often cited by papers focused on Catalytic C–H Functionalization Methods (2 papers), Computational Drug Discovery Methods (2 papers) and Natural Compound Pharmacology Studies (2 papers). Brian A. Sparling collaborates with scholars based in United States, Switzerland and United Kingdom. Brian A. Sparling's co-authors include Matthew D. Shair, David C. Moebius, Timothy F. Jamison, Ryan M. Moslin, Erin F. DiMauro, Graham L. Simpson, Kristin Goldberg, Yanyan Tudor, Ignacio Aliagas and Paul Richardson and has published in prestigious journals such as Journal of the American Chemical Society, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Brian A. Sparling

14 papers receiving 281 citations

Peers

Brian A. Sparling

PHARM

TOXIC

Akiyoshi Kuramochi Japan

Gabriel Bellavance Canada

Yuheng Hu China

Binh G. Vong United States

A. V. Nemtarev Russia

Hiroto Kaku Japan

László Juhász Hungary

Vincent Rodeschini France

Hideyuki Takenaka Japan

Shivajirao L. Gholap India

Akiyoshi Kuramochi Japan

Brian A. Sparling

361 ×2.1

103 ×1.1

127 ×1.4

70 ×1.1

PHARM

19 ×0.9

TOXIC

Citations per year, relative to Brian A. Sparling Brian A. Sparling (= 1×) peers Akiyoshi Kuramochi

Countries citing papers authored by Brian A. Sparling

Since Specialization

Citations

This map shows the geographic impact of Brian A. Sparling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Sparling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Sparling more than expected).

Fields of papers citing papers by Brian A. Sparling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Sparling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Sparling. The network helps show where Brian A. Sparling may publish in the future.

Co-authorship network of co-authors of Brian A. Sparling

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Sparling. A scholar is included among the top collaborators of Brian A. Sparling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Sparling. Brian A. Sparling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Sparling, Brian A., Hyelee Lee, Simina Grigoriu, et al.. (2025). Discovery of Kinesin KIF18A Inhibitor ATX020: Tactical Application of Silicon Atom Replacement. ACS Medicinal Chemistry Letters. 16(11). 2309–2319.

Lynes, Maureen S., Brian A. Sparling, Deepali Gotur, et al.. (2024). Abstract 3337: Inhibition of KIF18A leads to mitotic arrest and robust anti-tumor activity in chromosomally instable tumors. Cancer Research. 84(6_Supplement). 3337–3337. 1 indexed citations

Lockbaum, G.J., E. Allen Sickmier, Brian A. Sparling, et al.. (2023). Abstract B073: Characterization of selective, allosteric inhibitors of human XRN1. Molecular Cancer Therapeutics. 22(12_Supplement). B073–B073. 3 indexed citations

Daniels, Matthew H., Chuang Lu, David Brennan, et al.. (2023). Abstract 1136: Targeting DHX9 inhibition as a novel therapeutic modality in microsatellite instable colorectal cancer. Cancer Research. 83(7_Supplement). 1136–1136. 2 indexed citations

Jin, Hyun Yong, Yanyan Tudor, Kaylee Choi, et al.. (2019). High-Throughput Implementation of the NanoBRET Target Engagement Intracellular Kinase Assay to Reveal Differential Compound Engagement by SIK2/3 Isoforms. SLAS DISCOVERY. 25(2). 215–222. 11 indexed citations

Gao, Hua, Stephen E. Schneider, Paul S. Andrews, et al.. (2019). Virtual screening to identify potent sepiapterin reductase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(2). 126793–126793. 4 indexed citations

Meyer, James, Brian A. Sparling, William J. McCarty, et al.. (2019). Pharmacological Assessment of Sepiapterin Reductase Inhibition on Tactile Response in the Rat. Journal of Pharmacology and Experimental Therapeutics. 371(2). 476–486. 5 indexed citations

Sparling, Brian A. & Erin F. DiMauro. (2017). Progress in the discovery of small molecule modulators of the Cys-loop superfamily receptors. Bioorganic & Medicinal Chemistry Letters. 27(15). 3207–3218. 14 indexed citations

Aliagas, Ignacio, Kristin Goldberg, John Reilly, et al.. (2017). Sustainable Practices in Medicinal Chemistry Part 2: Green by Design. Journal of Medicinal Chemistry. 60(14). 5955–5968. 22 indexed citations

10.

Sparling, Brian A., Jessica Able, Howard Bregman, et al.. (2016). Discovery and hit-to-lead evaluation of piperazine amides as selective, state-dependent Na_V1.7 inhibitors. MedChemComm. 8(4). 744–754. 4 indexed citations

11.

Sparling, Brian A., et al.. (2016). Decarboxylative Anti-Michael Addition to Olefins Mediated by Photoredox Catalysis. Organic Letters. 18(14). 3494–3497. 45 indexed citations

12.

Sparling, Brian A., et al.. (2015). Total Synthesis of (−)-Nemorosone and (+)-Secohyperforin. Organic Letters. 17(14). 3398–3401. 36 indexed citations

13.

Sparling, Brian A., David C. Moebius, & Matthew D. Shair. (2012). Enantioselective Total Synthesis of Hyperforin. Journal of the American Chemical Society. 135(2). 644–647. 104 indexed citations

14.

Sparling, Brian A., Graham L. Simpson, & Timothy F. Jamison. (2008). Strategic use of nickel(0)-catalyzed enyne–epoxide reductive coupling toward the synthesis of (−)-cyatha-3,12-diene. Tetrahedron. 65(16). 3270–3280. 11 indexed citations

15.

Sparling, Brian A., Ryan M. Moslin, & Timothy F. Jamison. (2008). SmI₂-Promoted Reformatsky-Type Coupling Reactions in Exceptionally Hindered Contexts. Organic Letters. 10(6). 1291–1294. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact